21 results on '"Perez-Jaume, Sara"'
Search Results
2. Use of bevacizumab in pediatric low-grade glioma: Ten-year experience in a single center
3. EpiGe: A machine-learning strategy for rapid classification of medulloblastoma using PCR-based methyl-genotyping
4. Desensitizing the autonomic nervous system to mitigate anti-GD2 monoclonal antibody side effects
5. MIF/CXCR4 signaling axis contributes to survival, invasion, and drug resistance of metastatic neuroblastoma cells in the bone marrow microenvironment
6. Management of High-Risk Neuroblastoma with Soft-Tissue-Only Disease in the Era of Anti-GD2 Immunotherapy.
7. Early Salvage Chemo-Immunotherapy with Irinotecan, Temozolomide and Naxitamab Plus GM-CSF (HITS) for Patients with Primary Refractory High-Risk Neuroblastoma Provide the Best Chance for Long-Term Outcomes
8. Use of Bevacizumab in Pediatric Low-grade Glioma: Ten-year experience in a single center
9. Novel infusion strategy reduces severe adverse events caused by the anti-GD2 monoclonal antibody naxitamab
10. Naxitamab Combined with Granulocyte-Macrophage Colony-Stimulating Factor as Consolidation for High-Risk Neuroblastoma Patients in First Complete Remission under Compassionate Use—Updated Outcome Report
11. EpiGe: A machine-learning strategy for rapid classification of medulloblastoma using PCR-based methyl-genotyping
12. Follow‐up of intraocular retinoblastoma through the quantitative analysis of conserved nuclear DNA sequences in aqueous humor from patients
13. LGG-29. Use of Bevacizumab in Pediatric Low-grade Glioma: Ten-year experience in a single center
14. Follow‐up of intraocular retinoblastoma through the quantitative analysis of conserved nuclear DNA sequences in aqueous humor from patients.
15. Prognostic value of patient‐derived xenograft engraftment in pediatric sarcomas
16. Clinical and Pathological Evidence of Anti-GD2 Immunotherapy Induced Differentiation in Relapsed/Refractory High-Risk Neuroblastoma
17. Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment
18. IMMU-22. PHASE IB IMMUNOTHERAPY CLINICAL TRIAL WITH THE USE OF AUTOLOGOUS DENDRITIC CELLS PULSED WITH AN ALLOGENIC TUMORAL CELL LINES LYSATE IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
19. The Role of Autologous Stem-Cell Transplantation in High-Risk Neuroblastoma Consolidated by anti-GD2 Immunotherapy. Results of Two Consecutive Studies
20. EAPH-03. FINAL RESULTS OF THE PHASE II, SINGLE ARM TRIAL OF IRINOTECAN AND CISPLATIN IN CHILDREN WITH HIGH-RISK GLIAL TUMORS
21. ThresholdROC: Optimum Threshold Estimation Tools for Continuous Diagnostic Tests in R
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.